A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010–2012

References

• WelteT, TorresA, NathwaniD. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax2012; 67:71 - 9; http://dx.doi.org/10.1136/thx.2009.129502; PMID: 20729232
   PubMed Web of Science ®Google Scholar
• HoPL, ChiuSS, CheungCH, LeeR, TsaiTF, LauYL. Invasive pneumococcal disease burden in Hong Kong children. Pediatr Infect Dis J2006; 25:454 - 5; http://dx.doi.org/10.1097/01.inf.0000215004.85582.30; PMID: 16645513
   PubMed Web of Science ®Google Scholar
• McIntyreP, GilmourR, WatsonM. Differences in the epidemiology of invasive pneumococcal disease, metropolitan NSW, 1997-2001. N S W Public Health Bull2003; 14:85 - 9; http://dx.doi.org/10.1071/NB03026; PMID: 12806407
   PubMedGoogle Scholar
• JokinenC, HeiskanenL, JuvonenH, KallinenS, KarkolaK, KorppiM, KurkiS, RönnbergPR, SeppäA, SoimakallioS, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol1993; 137:977 - 88; PMID: 8317455
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2014. Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network, Streptococcus pneumoniae, 2012. Available at: http://www.cdc.gov/abcs/reports-findings/surv-reports.html [Last accessed July 2014]
   Google Scholar
• StupkaJE, MortensenEM, AnzuetoA, RestrepoMI. Community-acquired pneumonia in elderly patients. Aging health2009; 5:763 - 74; http://dx.doi.org/10.2217/ahe.09.74; PMID: 20694055
   PubMedGoogle Scholar
• LoebM. Pneumonia in the elderly. Curr Opin Infect Dis2004; 17:127 - 30; http://dx.doi.org/10.1097/00001432-200404000-00010; PMID: 15021052
   PubMedGoogle Scholar
• PletzMW, von BaumH, van der LindenM, RohdeG, SchütteH, SuttorpN, WelteT. The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ. Pneumologie2012; 66:470 - 5; http://dx.doi.org/10.1055/s-0032-1310103; PMID: 22875730
   PubMedGoogle Scholar
• Giorgi RossiP, AgabitiN, FaustiniA, AnconaC, TancioniV, ForastiereF, PerucciCA. The burden of hospitalised pneumonia in Lazio, Italy, 1997-1999. Int J Tuberc Lung Dis2004; 8:528 - 36; PMID: 15137527
   PubMed Web of Science ®Google Scholar
• ViegiG, PistelliR, CazzolaM, FalconeF, CerveriI, RossiA, Ugo Di MariaG. Epidemiological survey on incidence and treatment of community acquired pneumonia in Italy. Respir Med2006; 100:46 - 55; http://dx.doi.org/10.1016/j.rmed.2005.04.013; PMID: 16046113
   PubMed Web of Science ®Google Scholar
• della Salute M. Piano Nazionale Prevenzione Vaccinale (PNPV) 2012-14. Gazzetta Ufficiale n. 60 del 12.03.2012 (Supplemento Ordinario n.47). Italian Available from: http://www.salute.gov.it/imgs/c_17_pubblicazioni_1721_allegato.pdf
   Google Scholar
• MartinelliD, PedalinoB, CappelliMG, CaputiG, SallustioA, FortunatoF, TafuriS, CozzaV, GerminarioC, ChironnaM, et al, Apulian Group for the surveillance of pediatric IPD. Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013. Hum Vaccin Immunother2014; 10:33 - 9; http://dx.doi.org/10.4161/hv.26650; PMID: 24096297
   PubMed Web of Science ®Google Scholar
• DurandoP, FaustSN, FletcherM, KrizovaP, TorresA, WelteT. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect2013; 19:Suppl 11 - 9; http://dx.doi.org/10.1111/1469-0691.12320; PMID: 24083785
   PubMed Web of Science ®Google Scholar
• PilishviliT, LexauC, FarleyMM, HadlerJ, HarrisonLH, BennettNM, ReingoldA, ThomasA, SchaffnerW, CraigAS, et al, Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis2010; 201:32 - 41; http://dx.doi.org/10.1086/648593; PMID: 19947881
   PubMed Web of Science ®Google Scholar
• van der LindenM, WeißS, FalkenhorstG, SiedlerA, ImöhlM, von KriesR. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine2012; 30:5880 - 5; http://dx.doi.org/10.1016/j.vaccine.2012.06.068; PMID: 22771186
   PubMed Web of Science ®Google Scholar
• ZhouF, KyawMH, SheferA, WinstonCA, NuortiJP. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States. Arch Pediatr Adolesc Med2007; 161:1162 - 8; http://dx.doi.org/10.1001/archpedi.161.12.1162; PMID: 18056561
   PubMed Web of Science ®Google Scholar
• LeeGE, LorchSA, Sheffler-CollinsS, KronmanMP, ShahSS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics2010; 126:204 - 13; http://dx.doi.org/10.1542/peds.2009-3109; PMID: 20643717
   PubMed Web of Science ®Google Scholar
• KoshyE, MurrayJ, BottleA, SharlandM, SaxenaS. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax2010; 65:770 - 4; http://dx.doi.org/10.1136/thx.2010.137802; PMID: 20805169
   PubMed Web of Science ®Google Scholar
• DurandoP, CrovariP, AnsaldiF, SticchiL, SticchiC, TurelloV, MarensiL, GiacchinoR, TimitilliA, CarloniR, et al, Collaborative Group for Pneumococcal Vaccination in Liguria. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine2009; 27:3459 - 62; http://dx.doi.org/10.1016/j.vaccine.2009.01.052; PMID: 19200823
   PubMed Web of Science ®Google Scholar
• Resident population, by LHU in Tuscany, 2010. Available from: http://web.rete.toscana.it/demografia/?MIval=pop_ricerca [last accessed April 2014].
   Google Scholar
• Regional Health Agency of Tuscany. (ARS). Dossier: Introduzione universale della vaccinazione contro le patologie causate da Streptococcus pneumoniae nei bambini e negli adulti: prove di efficacia]. July 2007. Italian. Available from: http://www.epicentro.iss.it/ebp/pdf/strepto.pdf
   Google Scholar
• D’AnconaF, SalmasoS, BaraleA, BocciaD, LopalcoPL, RizzoC, MonacoM, MassariM, DemicheliV, PantostiA, Italian PNC-Euro working group. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine2005; 23:2494 - 500; http://dx.doi.org/10.1016/j.vaccine.2004.10.037; PMID: 15752836
   PubMed Web of Science ®Google Scholar
• MeritoM, Giorgi RossiP, MantovaniJ, CurtaleF, BorgiaP, GuasticchiG. Cost-effectiveness of vaccinating for invasive pneumococcal disease in the elderly in the Lazio region of Italy. Vaccine2007; 25:458 - 65; http://dx.doi.org/10.1016/j.vaccine.2006.08.005; PMID: 17049685
   PubMed Web of Science ®Google Scholar
• ButlerJC, SchuchatA. Epidemiology of pneumococcal infections in the elderly. Drugs Aging1999; 15:Suppl 111 - 9; http://dx.doi.org/10.2165/00002512-199915001-00002; PMID: 10690791
   PubMed Web of Science ®Google Scholar
• World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec2008; 83:373 - 84; PMID: 18927997
   PubMedGoogle Scholar
• van HoekAJ, AndrewsN, WaightPA, StoweJ, GatesP, GeorgeR, MillerE. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect2012; 65:17 - 24; http://dx.doi.org/10.1016/j.jinf.2012.02.017; PMID: 22394683
   PubMed Web of Science ®Google Scholar
• BonnelAR, BunchorntavakulC, ReddyKR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol2011; 9:727 - 38; http://dx.doi.org/10.1016/j.cgh.2011.02.031; PMID: 21397731
   PubMed Web of Science ®Google Scholar
• KyawMH, RoseCEJr., FryAM, SingletonJA, MooreZ, ZellER, WhitneyCG, Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis2005; 192:377 - 86; http://dx.doi.org/10.1086/431521; PMID: 15995950
   PubMed Web of Science ®Google Scholar
• AmodioE, CostantinoC, BoccaliniS, TramutoF, MaidaCM, VitaleF. Estimating the burden of hospitalization for pneumococcal pneumonia in a general population aged 50 years or older and implications for vaccination strategies. Hum Vaccin Immunother2014; 10; http://dx.doi.org/10.4161/hv.27947; PMID: 24577505
   PubMedGoogle Scholar
• AlicinoC, BarberisI, OrsiA, DurandoP. Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13 - valent polysaccharide conjugate vaccine. Minerva Med2014; 105:89 - 97; PMID: 24572454
   PubMed Web of Science ®Google Scholar
• BechiniA, BoccaliniS, BonanniP. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives. Vaccine2009; 27:3285 - 90; http://dx.doi.org/10.1016/j.vaccine.2009.01.058; PMID: 19200829
   PubMedGoogle Scholar
• PasinatoA, IndolfiG, MarchisioP, VallerianiC, CortimigliaM, SpanevelloV, ChiamentiG, BuzzettiR, RestiM, AzzariC, Italian Group for the Study of Bacterial Nasopharyngeal Carriage in Children. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine2014; 32:1375 - 81; http://dx.doi.org/10.1016/j.vaccine.2014.01.023; PMID: 24486364
   PubMed Web of Science ®Google Scholar